This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Researchers at the Indian Institute of Science (IISc) have found that picolinic acid, a natural compound produced by mammalian cells, can block several disease-causing viruses such as SARS-CoV-2 and influenza A viruses. The Institute is now looking for partners in pharmacompanies to pursue further clinical development of the findings.
Research and innovation in supply chain & logistics in the pharmaceutical sector has declined in the last year. The post Supply chain & logistics innovation among pharmacompanies has dropped off in the last year appeared first on Pharmaceutical Technology.
Indian healthcare providers and pharmacompanies pace up their efforts with early detection and research for new medicines to combat the spread of tuberculosis as drug resistance concerns emerge. TB is a significant public health threat, with an estimated 10 million annual cases. India shares the highest TB burden with 2.69
Medical meetings often feature important clinical trial results, making them barometers of biotech and pharmacompanies' research progress. Here’s a list of conferences to watch in 2025.
The Swiss pharmacompany is the latest large drugmaker to invest big in an experimental heart treatment, after years of prioritizing medicines for cancer and immune diseases.
While several therapeutics are available for treating symptoms associated with epilepsy, researchers and patients have strongly called out the need for more holistic treatments that would address the condition as a whole. Meanwhile, others are researching the link between gene variation and different responses to treatments.
Competitive intelligence is a vital tool of the research and analysis toolbox for firms wanting valuable data on their market, competitors and customers
Those, who don’t mind taking a risk in the business must reap the opportunity by launching a pharmacompany. Before you make up your mind about launching the pharma business, you should know about the investment requirements. There are various prerequisites and legal compliances before launching a pharmacompany.
The German pharmacompany has secured an option to acquire Trutino Biosciences, two years after inking a research collaboration with the San Diego drug developer.
Considering the low chances of success, with only 10% of drug candidates making it into clinical development, pharmacompanies must prevent the increased erosion of profit margins. This helps to reduce human error and provide more reliable, replicable results and increase the speed of drug discovery and development processes.
This long-term orientation also helps family businesses align their objectives more closely with those of society and patients and maintain flexibility to invest in important areas of the business including research and development, disease awareness, diagnostics and education. About the author.
Data is readily shared and leveraged for decision-makers to gain insight that can help clinical research. Jessica Hagen is a freelance life sciences and health writer and project manager who has worked with VR health companies, fiction/nonfiction authors, nonprofit and for-profit organisations, and government entities.
Further, 62% of HCPs said that the most significant area where pharma representatives can add value is, by understanding the needs of HCPs and sharing only relevant content with them to make the interactions more insightful. At the same time, marketing emails are among the top 5 channels used by pharmacompanies to engage HCPs.
In addition to collaborating with AI-technology providers, pharmacompanies are also engaging in vertical integration. One such emerging technology, artificial intelligence (AI), is expected to play an important role in the pharmaceutical sector in 2023. AI is still at the nascent stages of growth, but its potential is immense.
Israel-based AION Labs and German independent research institute BioMed X announced its third global call for applications to form a new start-up company focused on using AI to design and optimise antibodies for targeted therapies. . The post Big pharmacompanies partner to form AI-based start-up appeared first on.
Having made significant advances in a relatively short period of time, CRISPR research is now edging closer to reaching the clinic , and this month’s cover story takes a look at the major players in this field and the big events that could break through this year.
Today’s guest post comes from Steve Callahan, Senior Manager of Market Research at MMIT. Steve walks us through the expected Humira biosimilars launches and discusses potential responses from payers. To learn more, check out MMIT’s Strategic Launch Report & Evaluate Forecast solution. Read on for Steve’s insights.
Pharmaceutical companies can increase diversity in their clinical trials. Companies can also support pre-existing SDOH research initiatives. Studies should include as detailed SDOH data as possible. EVERSANA INTOUCH clients have done all of these things, and more.
The Department of Pharmaceuticals (DoP) has issued a new Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, permitting pharmacompanies to provide brand reminders such as informational and education items and free samples to medical professionals with restrictions on sample packs and total value.
The pharmacompanies’ thrust on R&D to develop better medicines and the demand in hospitals for advanced medical technologies driven by artificial intelligence, remote patient monitoring and wearables are transforming patient care.
Medical charity Alzheimer’s Research UK has teamed up with artificial intelligence specialist Exscientia to find new drug treatments for the devastating neurodegenerative disease. . It reckons its use of AI and machine learning can trim years off the current 12- to 15-year cycle from early research to marketed product.
Indian pharma sees immense value in US FDA’s insistence for aluminum content and labelling recommendations for the Small Volume Parenterals Drug Products and Pharmacy Bulk Packages. Pharmacompanies in the country have increasingly made a shift to nutritional based prescription and over the counter products.
QUICK READ: Recent research from Zoom Rx saying that digital interactions with HCPs are myopic and don’t apply to the heavily segmented HCP audience. Zoom Rx recently polled HCPs and found 78% of physicians want to maintain some contact with pharma reps. First, this data is not my specialty and is generalized.
Just 13% of people trust the pharmacompanies they interact with. If pharma is going to leap to a new era of marketing, they have to get to know their audiences. If pharma is going to leap to a new era of marketing, they have to get to know their audiences. 68% say the interactions feel transactional.
The Delhi High Court has granted ten days’ time to the Government of India and the nation’s drug regulator to file a counter affidavit on the petitions filed by almost 28 pharmacompanies against the order prohibiting manufacturing, distribution and sale of 14 FDCs licensed prior to the year 1988, in the beginning of June. […]
It is evident that HCPs are extremely time constraint and prefer to engage with pharma organizations on their terms regarding channel, content, and type of devices. In addition, 62% of HCPs are overwhelmed by product-related promotional content pushed by pharmacompanies on the various digital channels.
Research has shown that 74% of all U.S. This is one area where pharmacompanies can restore trust and excel. . ” 42% of Americans research their doctor’s suggestions after a visit. Over 75% of Americans use social media to research their health symptoms. . Of those, 80% turn online to do so.
Cell therapy research has been built on collaborations amongst scientists and entrepreneurs, providing early proof of concept for modalities thought to be too difficult to commercialise but with a strong potential for patient benefit”.
They told the researchers that insurance didn’t protect them from serious money problems. According to a team of Penn State College of Medicine researchers, care for the 15 most prevalent types of cancer in the U.S. (Stat News) Today, a study followed 380 patients being treated at community oncology groups across the U.S.
IN BRIEF: Pharmacompanies have been posting jobs on LinkedIn almost every day. While most offices remain closed pharma is preparing for the launch of new products and has to have the infrastructure to ensure a successful launch. They’re doing more online research and listening more to what other patients have to say.
Pharmacompanies have been investing deeply into digital advertising but vastly under measuring customer engagement and other metrics. Pharma marketers spend countless hours developing PowerPoints and getting approval for tactics, but they need specific listening metrics to pivot quickly if their plans aren’t effective.
1ne: Pharmacompanies are forcing out older, experienced employees. 2wo: Talented marketing people don’t want to work in pharma because of the culture. 3hree: Pharma-only agencies have forced out people who created great campaigns and replaced them with people who are too anxious to make a name for themselves.
While large pharmacompanies have been slow in this area, Merck and GSK are now using 3D printing for clinical trials and manufacturing. Orthopaedic companies have been using 3D printing for their implants for years. 3D bioprinting offers an alternative to animal testing in drug development.
Collaborative partnerships between universities and pharmaceutical companies are crucial for advancing biomedical research and development (R&D) and creating groundbreaking medicines. Explore the benefits and significance of these alliances in this informative piece.
Medscape conducted some research in May to find out. Digital channels play a far greater role in communication between pharmacompanies and healthcare professionals than before the pandemic. . Of course Medscape used this research as a self-promotion to show increases in their online metrics. Medscape Detailed Findings.
While most agreed that digital plays an important role now they feel that when patients return to the office HCP’s won’t have the time to go online with every drug company that is requesting an online detail. For companies that don’t put in the time or effort to continually the improve the online experience, it will fail.
So why is pharma wasting so much money? Research has shown that only 35% of digital display ads received views. The behavior of online health seekers also differs by the stage of their research. Until pharmacompanies invest in a digital department with experienced digital marketers, the problems, and waste, will continue.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
189 
Let's personalize your content